EPODIN works to ensure that European public health policies take into account the specific needs of people affected by dysimmune and inflammatory neuropathies (DINs). We are fully committed working with Member States, MEPs and European Commission in the interest of patients.
Download PDF :
EPODIN Position paper as to the proposed EU SoHO Regulation 22/09/2023
EPODIN_Position on EC proposed EU Pharma Directive_November2023
EPODIN_Position on EU COM proposed EU Pharma Regulation_Nov2023
EPODIN_Position on EU Council mandate for trilogue negotiations on SoHO Regulation_27October2023
